Recent News

By Category: Biological Weapons

FDA Lifts Clinical Hold On PharmAthene’s SparVax(R) Anthrax Vaccine Program

(TheWallStreetJournal) PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on a proposed Phase II study of SparVax(R) , a next generation recombinant anthrax vaccine. “We are very pleased by the Read More »

May 31, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Public Health, and Research
Share

Experimental Drug Could Treat Child Bioterrorism Victims

(GlobalSecurityNewswire) The United States on Friday announced a $17.7 million push to secure federal licensure of an experimental antibiotic officials believe could treat young victims of anthrax or tularemia bacteria. Announcement of the two-year research and development deal with a North Carolina pharmaceutical firm came weeks after congressional investigators warned that minors could have only Read More »

May 29, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Policy & Initiatives, and Research
Share

Army Seeks Contract Support for Biosurveillance Centers

(Global Biodefense) The U.S. Army is soliciting proposals for contract support of Avian Influenza/Pandemic Influenza (AI/IP) and Other Emerging Disease Surveillance at the Armed Forces Health Surveillance Center (AFHSC) and Department of Defense (DoD) Global Emerging Infections Surveillance and Response System (DoD-GEIS) in Silver Spring, MD. Provision of personnel, facilities, materials, management, preparation, and completion Read More »

May 28, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Countermeasures, Policy & Initiatives, and Public Health
Share

Kansas to break ground on NBAF project

(CJOnline) After several years of political and fiscal wrangling, Kansas officials are preparing to formally break ground on a new federal biodefense lab in Manhattan. Officials including Gov. Sam Brownback and leaders of Kansas State University will hold a ceremony Tuesday as ground is broken for the lab’s utility plant. It marks the start of Read More »

May 28, 2013
| Filed under North America, Biological Weapons, Biosafety, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

Chapel Hill drug firm Cempra lands bioterror antibiotic contract worth up to $58M

(WRAL) Cempra (Nasdaq: CEMP) has won a contract worth as much as $58 million over five years from the Biomedical Advanced Research and Development Authority (BARDA) for development of an antibiotic that could be used by young people and to counter bioterror threats. The company has secured a two-year deal worth $17 million to work Read More »